Clinical Trials · NCT04027712
Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- University of Athens
- Enrollment
- 120
- Start date
- Jan 2014
- Locations
- 1 site, Greece
- Primary endpoint
- mots-c predicts cardiovascular mortality in diabetic with coronary artery disease